Evaluation of Two Point of Care Technologies for Measuring Monoclonal Antibody Therapeutic-Aconcentrations in Blood
- 25 September 2020
- journal article
- research article
- Published by Taylor & Francis in Bioanalysis
- Vol. 12 (20) , 1449-1458
Abstract
Aim: Current blood monitoring methods require sample collection and testing at a central lab, which can take days. Point of care (POC) devices with quick turnaround time can provide an alternative ...Keywords
Funding Information
- Genentech
This publication has 18 references indexed in Scilit:
- Point-of-Care and Utility in Clinical Trials: Making Quicker Decisions to Transform Patient Care and Drug DevelopmentBioanalysis, 2020
- Development of an IL-6 Point-of-Care Assay: Utility for Real-Time Monitoring and Management of Cytokine Release Syndrome and SepsisBioanalysis, 2019
- Accuracy of the new rapid test for monitoring adalimumab levelsTherapeutic Advances in Gastroenterology, 2019
- Individualized Dosing of Therapeutic Monoclonal Antibodies—a Changing Treatment Paradigm?The AAPS Journal, 2018
- Precision dosing of targeted anticancer drugs—challenges in the real worldTranslational Cancer Research, 2017
- Point-of-Care Technologies for Precision Cardiovascular Care and Clinical ResearchJACC: Basic To Translational Science, 2016
- Therapeutic Drug Monitoring of Biologics for Inflammatory Bowel DiseaseInflammatory Bowel Diseases, 2012
- Finger-Stick Glucose MonitoringDiabetes Care, 2010
- Abnormal laboratory results: Therapeutic drug monitoring: which drugs, why, when and how to do itAustralian Prescriber, 2008
- Cardiac markers: point of care testingClinica Chimica Acta, 1999